S&P 500 7,370.81 â–ŧ 101.98 (-1.36%) DOW 51,692.85 â–ŧ 19.86 (-0.04%) NASDAQ 25,611.30 â–ŧ 555.30 (-2.12%) US Markets Closed â€ĸ 04:08 PM ET

FZMD

Fuse Medical, Inc.

Price Chart
Latest Quote

$0.02

+0.00 (+0.00%)
Current Price
Previous Close $0.02
Open $0.02
Day High $0.02
Day Low $0.02
Volume 1
Fetched: 2026-06-23T20:08:32
Stock Information
Shares Outstanding 73.90M
Total Debt $2.22M
Cash Equivalents $253K
Revenue $18.40M
Net Income $3.98M
Sector Healthcare
Industry Medical Devices
Market Cap $1.48M
P/E Ratio 1.00
EPS (TTM) $0.02
Exchange PNK
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$3.51M
Sales$18.40M
Income$3.98M
Book/sh$-0.00
Cash/sh$0.00
Financial Ratios
Quick Ratio0.31
Current Ratio1.06
Returns & Margins
ROA0.35%
Gross Margin67.25%
Operating Margin7.38%
Profit Margin21.61%
Ownership
Insider Ownership86.89%
Insider & Institutional transactions data not available
Valuation Ratios
P/S0.08
P/B-6.67
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.03
SMA50$0.03
SMA200$0.05
ATR0.0007
Shares Float6.12M
Volatility-0.52
Rel Volume0.10
Performance History
Week+0.00%
Month-33.33%
Quarter-50.00%
6 Months-71.43%
YTD+0.00%
Year-71.43%
3 Years-66.67%
5 Years-84.62%
10 Years-83.33%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-22 $0.02 600
2026-06-18 $0.02 0
2026-06-17 $0.02 0
2026-06-16 $0.02 0
2026-06-15 $0.02 0
2026-06-12 $0.02 0
2026-06-11 $0.02 0
2026-06-10 $0.02 119,300
2026-06-09 $0.03 0
2026-06-08 $0.03 0
2026-06-05 $0.03 0
2026-06-04 $0.03 0
2026-06-03 $0.03 0
2026-06-02 $0.03 0
2026-06-01 $0.03 0
2026-05-29 $0.03 0
2026-05-28 $0.03 0
2026-05-27 $0.03 0
2026-05-26 $0.03 0
About Fuse Medical, Inc.

Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company provides orthopedic implants, including internal and external fixation products; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, substitute bone materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Farmers Branch, Texas.

📰 Latest News
No news articles available at the moment. Check back later for updates on FZMD.
Period:
Loading...
Income Statement (Annual)
Metric 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $7,103,033 $8,478,561
Cost Of Revenue $7,103,033 $8,478,561
Total Revenue $18,644,784 $20,414,268
Operating Revenue $18,644,784 $20,414,268
Expenses
Interest Expense $171,294 $78,230
Total Expenses $19,459,856 $22,609,774
Other Income Expense $4,108,134 $703,568
Net Non Operating Interest Income Expense $-171,294 $-78,230
Interest Expense Non Operating $171,294 $78,230
Operating Expense $12,356,823 $14,131,213
Selling And Marketing Expense $5,682,038 $7,050,278
General And Administrative Expense $6,537,382 $7,013,297
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $3,098,113 $-1,587,891
Net Interest Income $-171,294 $-78,230
Normalized Income $-977,156 $-2,101,496
Net Income From Continuing And Discontinued Operation $3,098,113 $-1,587,891
Total Operating Income As Reported $-815,072 $-2,195,506
Net Income Common Stockholders $3,098,113 $-1,587,891
Net Income $3,098,113 $-1,587,891
Net Income Including Noncontrolling Interests $3,098,113 $-1,587,891
Net Income Continuous Operations $3,098,113 $-1,587,891
Pretax Income $3,121,768 $-1,570,168
Special Income Charges $4,108,134 $703,568
Operating Income $-815,072 $-2,195,506
Depreciation Amortization Depletion Income Statement $137,403 $67,638
Depreciation And Amortization In Income Statement $137,403 $67,638
Gross Profit $11,541,751 $11,935,707
Per Share
Diluted EPS $0.04 $-0.02
Basic EPS $0.04 $-0.02
Other
Tax Effect Of Unusual Items $32,865 $189,963
Tax Rate For Calcs $0 $0
Normalized EBITDA (Bullshit earnings) $-677,669 $-2,127,868
Total Unusual Items $4,108,134 $703,568
Total Unusual Items Excluding Goodwill $4,108,134 $703,568
Reconciled Depreciation $137,403 $67,638
EBITDA (Bullshit earnings) $3,430,465 $-1,424,300
EBIT $3,293,062 $-1,491,938
Diluted Average Shares $73,895,794 $70,321,566
Basic Average Shares $73,895,794 $70,321,566
Diluted NI Availto Com Stockholders $3,098,113 $-1,587,891
Tax Provision $23,655 $17,723
Restructuring And Mergern Acquisition $-4,108,134 $-342,168
Selling General And Administration $12,219,420 $14,063,575
Other Gand A $6,537,382 $7,013,297
Other Special Charges - $-361,400
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-3,474,720 $-6,722,046
Total Assets $19,762,581 $18,304,492
Total Non Current Assets $5,997,339 $5,479,915
Non Current Accounts Receivable $2,832,764 $2,182,437
Goodwill And Other Intangible Assets $3,163,866 $3,290,227
Other Intangible Assets $1,190,980 $1,317,341
Current Assets $13,765,242 $12,824,577
Other Current Assets $126,022 $5,921
Inventory $9,494,506 $8,736,474
Receivables $3,996,860 $3,528,992
Accounts Receivable $3,996,860 $3,528,992
Allowance For Doubtful Accounts Receivable $-290,500 $-498,261
Gross Accounts Receivable $4,287,360 $4,027,253
Cash Cash Equivalents And Short Term Investments $147,854 $553,190
Cash And Cash Equivalents $147,854 $553,190
Prepaid Assets - $5,921
Debt
Net Debt $2,199,281 $2,229,580
Total Debt $2,347,135 $2,782,770
Long Term Debt And Capital Lease Obligation $200,000 $200,000
Long Term Debt $200,000 $200,000
Current Debt And Capital Lease Obligation $2,147,135 $2,582,770
Current Debt $2,147,135 $2,582,770
Other Current Borrowings $150,000 $150,000
Liabilities
Total Liabilities Net Minority Interest $20,073,435 $21,736,311
Total Non Current Liabilities Net Minority Interest $7,685,698 $11,793,832
Other Non Current Liabilities $7,485,698 $11,593,832
Current Liabilities $12,387,737 $9,942,479
Payables And Accrued Expenses $10,240,602 $7,359,709
Payables $5,700,236 $4,461,641
Accounts Payable $5,700,236 $4,461,641
Current Notes Payable - $0
Equity
Common Stock Equity $-310,854 $-3,431,819
Total Equity Gross Minority Interest $-310,854 $-3,431,819
Stockholders Equity $-310,854 $-3,431,819
Retained Earnings $-2,518,086 $-5,616,199
Other
Ordinary Shares Number $73,895,794 $72,895,793
Share Issued $73,895,794 $72,895,793
Tangible Book Value $-3,474,720 $-6,722,046
Invested Capital $2,036,281 $-649,049
Working Capital $1,377,505 $2,882,098
Total Capitalization $-110,854 $-3,231,819
Additional Paid In Capital $1,468,274 $1,455,422
Capital Stock $738,958 $728,958
Common Stock $738,958 $728,958
Preferred Stock $0 $0
Line Of Credit $1,997,135 $2,432,770
Current Accrued Expenses $4,540,366 $2,898,068
Goodwill $1,972,886 $1,972,886
Net PPE $709 $7,251
Accumulated Depreciation $-19,540 $-12,998
Gross PPE $20,249 $20,249
Machinery Furniture Equipment $20,249 $20,249
Finished Goods $9,494,506 $8,736,474
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $34,799 $-1,778,328
Operating Activities
Operating Cash Flow $34,799 $-1,778,328
Cash Flow From Continuing Operating Activities $34,799 $-1,778,328
Operating Gains Losses - $-361,400
Investing Activities
Investing Cash Flow $0 $0
Cash Flow From Continuing Investing Activities $0 $0
Financing Activities
Financing Cash Flow $-440,135 $1,144,060
Cash Flow From Continuing Financing Activities $-440,135 $1,144,060
Other
Repayment Of Debt $-440,135 $-1,649,710
Issuance Of Debt $0 $2,782,770
Interest Paid Supplemental Data $160,447 $42,830
Income Tax Paid Supplemental Data $18,052 $19,581
End Cash Position $147,854 $553,190
Beginning Cash Position $553,190 $1,187,458
Changes In Cash $-405,336 $-634,268
Proceeds From Stock Option Exercised $0 $11,000
Net Issuance Payments Of Debt $-440,135 $1,133,060
Net Short Term Debt Issuance $-440,135 $1,283,060
Short Term Debt Payments $-440,135 $-1,149,710
Net Long Term Debt Issuance $0 $-150,000
Long Term Debt Payments $0 $-500,000
Long Term Debt Issuance $0 $350,000
Net PPE Purchase And Sale $0 $0
Purchase Of PPE $0 $0
Change In Working Capital $-596,173 $324,071
Change In Payables And Accrued Expense $2,880,893 $1,538,383
Change In Accrued Expense $1,642,298 $313,334
Change In Payable $1,238,595 $1,225,049
Change In Account Payable $1,238,595 $1,225,049
Change In Prepaid Assets $-120,101 $18,282
Change In Inventory $-1,471,042 $-1,168,516
Change In Receivables $-1,885,923 $-64,078
Changes In Account Receivables $-1,885,923 $-64,078
Other Non Cash Items $-4,108,134 $-342,168
Stock Based Compensation $22,852 $257,913
Provisionand Write Offof Assets $1,480,738 $-136,491
Depreciation Amortization Depletion $137,403 $67,638
Depreciation And Amortization $137,403 $67,638
Amortization Cash Flow $130,861 $57,097
Amortization Of Intangibles $130,861 $57,097
Depreciation $6,542 $10,540
Net Income From Continuing Operations $3,098,113 $-1,587,891
Short Term Debt Issuance - $2,432,770
Fetched: 2026-02-02